Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Discovery of lipid biomarkers for idiopathic Parkinson's disease in red blood cells and plasma.

NPJ Parkinson's disease·2026
Same author

Copper isotope shifts in biofluids track Alzheimer's pathology.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Cu(ATSM) Restores Blood-Brain Barrier Abundance of P-Glycoprotein and Improves Cognitive Function in the APP/PS1 Mouse Model of Alzheimer's Disease.

ACS chemical neuroscience·2026
Same author

Ferroptosis susceptibility in hippocampal neural precursor cells influences neurogenesis and memory across aging.

Cell stem cell·2026
Same author

Mitochondrially Transcribed DsRNA Mediates Manganese-Induced Neuroinflammation.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Distinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis.

Molecular biology of the cell·2026
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Pratishtha Chatterjee1,2,3, Pawel Kalinowski4, Anne M Roberts5

  • 1The Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

低脑脊液粉样蛋白前体蛋白 (APP) 水平与阿尔茨海默病 (AD) 痴呆症有关,特别是在具有酸化 (p-tau) 病理的人群中. 这一发现有助于理解非典型的AD生物标志物概况.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物
  • 阿尔茨海默病病理生理病理学

背景情况:

  • 生物标志物 (粉样β和酸化) 的整合改善了阿尔茨海默病 (AD) 的诊断.
  • 非典型的生物标志物概况 (例如,粉样β阳性/酸化阳性) 在临床诊断的阿尔茨海默病例中的15-20%发生,这给诊断带来了挑战.
  • 在这些非典型病例中,研究AD类症状的替代病理生理机制至关重要.

研究的目的:

  • 为了研究大脑脊髓液 (CSF) 粉样蛋白前体蛋白 (APP) 在临床诊断的AD患者中的作用.
  • 探索CSF APP水平与不同生物标志物概况 (粉样β和酸化状态) 之间的关系.
  • 了解APP干扰对AD进展和认知衰退的贡献.

主要方法:

  • 在两个独立的队列中分析CSF APP度:ADNI (N=384) 和ADC (N=419).
  • 对APP含量与酸化陶 (p-tau181) 和Aβ42/Aβ40比率的相关性分析.
  • 评估APP水平与其他生物标志物 (NfL) 和认知/功能评分 (MMSE,CDR-SB) 之间的关联.

主要成果:

  • 在所有诊断组中,与酸化阳性 (T+) 个体相比,酸化阳性 (T-) 个体的CSF APP显著较低.
  • 在临床AD诊断的T-病例中,APP减少最为明显.
  • 较低的APP水平,特别是与升高的p-tau181相结合时,与阿尔茨海默氏症类痴呆症的最高患病率以及最严重的认知和功能障碍有关.

结论:

  • 低APP水平或高的p-tau181与AD类痴呆症的高患病率有关,当两种标志物都存在时,观察到的最大风险.
  • 这些发现揭示了临床诊断的AD中T-状态的独特生物学特征,突出了诊断改进的潜力.
  • 在APP的生产和处理中出现的障碍可能会导致AD的进展,影响神经元可塑性和认知功能.